Nurcan Bektas

Nurcan Bektas

Auto-generated profile, based on publicly available information

Nurcan Bektas

Anadolu University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
NBNurcan Bektas
Nurcan Bektas
BŞBehiye Şenel
Behiye Şenel
Evrim AKYILEvrim AKYIL
Evrim AKYIL
OÖOrhan Özatik
Orhan Özatik
RARana Arslan
Rana Arslan
Acute or chronic wounds are one of the most common health problems worldwide and medicinal drugs or traditional remedies are often used in wound healing. Further studies regarding wound treatment are rapidly continuing. Vitexin is a phenolic compound, which is found in many medicinal plants, has different pharmacological effects such as anti-inflammatory, analgesic and antioxidant. In the present study, it is aimed to investigate the wound healing effect of formulation prepared as chitosan-based gel with vitexin in vivo and in vitro. Cytotoxicity and wound healing assays were used for in vitro and excisional wound model is used for in vivo studies. Extracted tissues from wound area were histologically examined. Wound healing process was monitored on 7, 14 and 21st days. When wound construction was evaluated, chitosan-based gel formulation containing vitexin demonstrated significant effect compared to control group. Histological examinations demonstrated that skin regeneration was promoted by vitexin formulation. Significant cell proliferation was observed with vitexin/chitosan dispersion in the wound healing assay performed with NIH 3T3 and HaCaT cells. In conclusion, our test substance chitosan-based gel formulation containing vitexin significantly accelerated wound healing both in vivo and in vitro.

1 May 2018 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
RARana Arslan
Rana Arslan
SASule Aydin
Sule Aydin
DSDilara Nemutlu Samur
Dilara Nemutlu Samur
NBNurcan Bektas
Nurcan Bektas
It is aimed to investigate the central antinociceptive effect of protocatechuic acid and the involvement of stimulation of opioidergic, serotonin 5-HT2A/2C, α2-adrenergic and muscarinic receptors in protocatechuic acid-induced central analgesia in mice. Time-dependent antinociceptive effects of protocatechuic acid at the oral doses of 75, 150 and 300 mg/kg were tested in hot-plate (integrated supraspinal response) and tail-immersion (spinal reflex) tests in mice. To investigate the mechanisms of action; the mice administered 300 mg/kg protocatechuic acid (p.o.) were pre-treated with non-specific opioid antagonist naloxone (5 mg/kg, i.p.), serotonin 5-HT2A/2C receptor antagonist ketanserin (1 mg/kg, i.p.), α2-adrenoceptor antagonist yohimbine (1 mg/kg, i.p.) and non-specific muscarinic antagonist atropine (5 mg/kg, i.p.), respectively. The antinociceptive effect of protocatechuic acid was observed at the doses of 75, 150 and 300 mg/kg in tail-immersion test, at the doses of 150 and 300 mg/kg in hot-plate test at different time interval. The enhancement in the latency of protocatechuic acid-induced response to thermal stimuli was antagonized by yohimbine, naloxone and atropine in tail-immersion test, while it was antagonized only by yohimbine and naloxone pretreatments in hot-plate test. These results indicated that protocatechuic acid has the central antinociceptive action that is probably organized by spinal mediated cholinergic and opiodiergic, also spinal and supraspinal mediated noradrenergic modulation. However, further studies are required to understand how protocatechuic acid organizes the interactions of these modulatory systems. As a whole, these findings reinforce that protocatechuic acid is a potential agent that might be used for pain relief. Additionally, the clarification of the effect and mechanisms of action of protocatechuic acid will contribute to new therapeutic approaches and provide guidance for new drug development studies.

1 June 2012 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
NBNurcan Bektas
Nurcan Bektas
RARana Arslan
Rana Arslan
FGFatih Goger
Fatih Goger
NKNese Kirimer
Nese Kirimer
YOYusuf Ozturk
Yusuf Ozturk

1 January 2014 in Life Sciences
Verified
Journal Article
Closed access
NBNurcan Bektas
Nurcan Bektas
RARana Arslan
Rana Arslan
YOYusuf Ozturk
Yusuf Ozturk

1 November 2020 in Life Sciences
Verified
Journal Article
Closed access
NBNurcan Bektas
Nurcan Bektas
RARana Arslan
Rana Arslan
FAFeyza Alyu
Feyza Alyu

1 September 2015 in Indian Journal of Pharmacology
Verified
Journal Article
Open access
NBNurcan Bektas
Nurcan Bektas
DNDilara Nemutlu
Dilara Nemutlu
RARana Arslan
Rana Arslan
Pain is an unpleasant experience and effects daily routine negatively. Although there are various drugs, many of them are not entirely successful in relieving pain, since pain modulation is a complex process involving numerous mediators and receptors. Therefore, it is a rational approach to identify the factors involved in the complex process and develop new agents that act on these pain producing mechanisms. In this respect, the involvement of the imidazoline receptors in pain modulation has drawn attention in recent years. In this review, it is aimed to focus on the imidazoline receptors and their ligands which contribute to the pain modulation. It is demonstrated that imidazoline-2 (I 2 ) receptors are steady new drug targets for analgesics. Even if the mechanism of I 2 receptor is not well known in the modulation of pain, it is known that it plays a role in tonic and chronic pain but not in acute phasic pain. Moreover, the I 2 receptor ligands increase the analgesic effects of opioids in both acute and chronic pain and prevent the development of opioid tolerance. So, they are valuable for the chronic pain treatment and also therapeutic coadjuvants in the management of chronic pain with opiate drugs due to the attenuation of opioid tolerance and addiction. Thus, the use of the ligands which bind to the imidazoline receptors is an effective strategy for relieving pain. This educational forum exhibits the role of imidazoline receptors and ligands in pain process by utilizing experimental studies.